Open an account

CapForce IBD 50 ETF

FFTY · ETF

$33.48+$0.5371 (+1.63%)TodayMarket closed ·
Prev close $32.94

About FFTY

FFTY was created on 2015-04-09 by CapForce. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 68.92m in AUM and 52 holdings. FFTY tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings. The fund can toggle to 50% T-bills based on market technical signals.

Issuer
CapForce
Tracks
IBD 50 TR
Expense ratio
0.8%
Assets under management
$64.09M
Inception
Apr 9, 2015
Asset class
Equity
Website
capforceetf.com

FFTY key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
20.68K
Volume
42.98K
Open price
$33.05
High today
$33.60
Low today
$33.05
52 Week high
$44.08
52 Week low
$32.07

CapForce IBD 50 ETF (FFTY) at a glance

CapForce IBD 50 ETF (FFTY) last traded at $33.48, with a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $33.05 and $33.60. The current price is 1.3% above the day's low and 0.4% below its high.

Volume so far is 42.98K shares, above the average of 20.68K shares a day.

Over the past year CapForce IBD 50 ETF has ranged from $32.07 to $44.08, and now sits 12% of the way up that range.

FFTY news

  • Chandrima Sanyal

    Smart Beta Meets IBD: CapForce Rebrands Innovator's IBD Funds In Rules-Based Push

  • Press releaseBusiness Wire

    Capital-FORCE Welcomes IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs to New Rules-Based ETF Platform

  • Press releaseBusiness Wire

    Capital-FORCE Enters ETF Market with Acquisition of Innovator IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs

  • Press releaseGlobe Newswire

    Innovator Announces Results of Special Meeting of Shareholders Relating to the Reorganizations of Innovator IBD® Breakout Opportunities ETF and Innovator IBD® 50 ETF

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.